recombinant TACE-2 inhibitors (Meyer Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerecombinant TACE-2 inhibitors (Meyer Pharmaceuticals)
Drug Alias Namerecombinant TNF-alpha release/signaling inhibitors (Meyer Pharmaceuticals)MP-70MP-72
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeyer Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeyer Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A